Literature DB >> 7824731

Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies.

B L Shulkin1, D S Mitchell, D R Ungar, D Prakash, M G Dole, V P Castle, R J Hernandez, R A Koeppe, R J Hutchinson.   

Abstract

PURPOSE: To assess the uptake of 2-[fluorine-18]-fluoro-2-deoxy-D-glucose (FDG) in common and uncommon tumors in children and to develop a method for performing positron emission tomography (PET) studies in children with malignant neoplasms.
MATERIALS AND METHODS: Twenty-two pediatric patients with known or suspected malignancies (27 scans) underwent FDG PET. Tumor uptake of FDG was measured on PET scans.
RESULTS: Tumor uptake of FDG was detected in 17 of 21 patients with malignant disease. Neuroblastomas and their metastases (including those that did not absorb metaiodobenzylguanidine) intensely accumulated FDG. In a patient with Ewing sarcoma, FDG PET showed two foci of metastatic disease not evident on bone scans. In two patients, PET showed that large areas of the tumor were necrotic.
CONCLUSION: FDG PET is feasible, is useful in the study of tumors in children, and may provide unique, clinically important information.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7824731     DOI: 10.1148/radiology.194.2.7824731

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  17 in total

Review 1.  PET imaging in pediatric oncology.

Authors:  Barry L Shulkin
Journal:  Pediatr Radiol       Date:  2004-01-27

Review 2.  18F-PET-CT in extracranial paediatric oncology: when and for whom is it useful?

Authors:  Sue C Kaste
Journal:  Pediatr Radiol       Date:  2008-06

3.  Positron emission tomography in recurrent hepatoblastoma.

Authors:  Isaac Philip; Albert Shun; Geoffrey McCowage; Robert Howman-Giles
Journal:  Pediatr Surg Int       Date:  2005-04-15       Impact factor: 1.827

Review 4.  Where are we with nuclear medicine in pediatrics?

Authors:  H R Nadel
Journal:  Eur J Nucl Med       Date:  1995-12

5.  Value of FDG-PET/CT examinations in different cancers of children, focusing on lymphomas.

Authors:  Edit Bárdi; Mónika Csóka; Ildikó Garai; István Szegedi; Judit Müller; Tamás Györke; Kornélia Kajáry; Karolina Nemes; Csongor Kiss; Gábor Kovács
Journal:  Pathol Oncol Res       Date:  2013-08-17       Impact factor: 3.201

Review 6.  [Simultaneous whole-body PET-MRI in pediatric oncology : More than just reducing radiation?].

Authors:  S Gatidis; B Gückel; C la Fougère; J Schmitt; J F Schäfer
Journal:  Radiologe       Date:  2016-07       Impact factor: 0.635

7.  Brown adipose tissue 18F-FDG uptake in pediatric PET/CT imaging.

Authors:  Terence S Hong; Amer Shammas; Martin Charron; Katherine A Zukotynski; Laura A Drubach; Ruth Lim
Journal:  Pediatr Radiol       Date:  2010-12-16

8.  Ewing sarcoma: an eponym window to history.

Authors:  Timothy P Cripe
Journal:  Sarcoma       Date:  2010-12-01

9.  FDG PET imaging of childhood sarcomas.

Authors:  Rajen J Mody; Chuong Bui; Raymond J Hutchinson; Greg A Yanik; Valerie P Castle; Kirk A Frey; Barry L Shulkin
Journal:  Pediatr Blood Cancer       Date:  2010-02       Impact factor: 3.167

Review 10.  123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.

Authors:  Gitta Bleeker; Godelieve A M Tytgat; Judit A Adam; Huib N Caron; Leontien C M Kremer; Lotty Hooft; Elvira C van Dalen
Journal:  Cochrane Database Syst Rev       Date:  2015-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.